NSTLFuzhouPeople’s Republic of ChinaAsiaAlcohol-Induced Diseases and ConditionsAlcoholic Fatty LiverAlcoholismAr terial Occlusive DiseasesArteriosclerosisAtherosclerosisBioengineeringBi oinformaticsBiomarkersBiotechnologyCardiovascular Diseases and ConditionsCyborgsDiagnostics and ScreeningDigestive System Diseases and ConditionsD rugs and TherapiesEmerging TechnologiesFatty LiverFatty Liver DiseaseGen eticsHealth and MedicineInformation TechnologyLiver Diseases and Condition sMachine LearningNon-Alcoholic Fatty Liver DiseasePharmaceuticalsRisk an d Prevention
2024
